Septic shock: Beta-lactam levels unpredictable, need close monitoring (Review, Crit Care) - PulmCCM
Advertisement
Oct 062011
 

Goncalves-Pereira and Povoa meta-reviewed 57 reviews of pharmacokinetics of common beta-lactam antibiotics (piperacillin, meropenem, cefepime, ceftazidime, etc.) on patients in ICUs.

The results were troubling or at least confusing: studies reported wide variability in pharmacokinetics of beta-lactam antibiotics in critically ill patients, with volume of distribution and drug clearance varying more than 2-fold for the same drugs in similar patient populations.

The net result is that the time spent above minimum inhibitory concentration (T>MIC) — i.e., the expectation that therapeutic levels are present at usual dosing — was totally unpredictable. Tissue penetration was also compromised in patients with septic shock.

Their conclusion: Check levels often and dose drugs accordingly. My conclusion: get to know and love your friendly neighborhood ICU pharmacist.

Joao Goncalves-Pereira and Pedro Povoa. Antibiotics in critically ill patients – a systematic review of the pharmacokinetics of beta-Lactams. Critical Care 2011, 15:R206. FREE FULL TEXT

Liked this post? Get a weekly email update (no spam, ever), and explore our library of pulmonary and critical care guidelines, practice updates and review articles.

PulmCCM is an independent publication, not affiliated with or endorsed by any other organization, society and/or journal referenced on the website.

Leave a Comment